Oncology Institute (TOIIW) Short-term Investments (2022 - 2024)

Oncology Institute (TOIIW) has reported Short-term Investments for 3 consecutive years, with $9.9 million the latest figure, recorded in Q2 2024.

• Short-term Investments for Q2 2024 came in at $9.9 million, down 3.42% year-over-year; the trailing twelve-month figure through Jun 2024 was $9.9 million (down 3.42% YoY), and the FY2023 annual result was $49.4 million, down 17.44% from the prior year.
• Short-term Investments was $9.9 million for Q2 2024 at Oncology Institute, down from $29.8 million in the prior quarter.
• Over five years, Short-term Investments peaked at $59.9 million in Q3 2023 and troughed at $9.9 million in Q2 2024.
• Average Short-term Investments over 3 years is $36.0 million, with a median of $35.0 million recorded in 2023.
• Year-over-year, Short-term Investments soared 105.38% in 2023 and retreated 25.8% in 2024.
• Over 3 years, Short-term Investments stood at $59.8 million in 2022, then slipped by 17.44% to $49.4 million in 2023, then slumped by 79.87% to $9.9 million in 2024.
• Per Business Quant data, the three most recent Short-term Investments figures were $9.9 million in Q2 2024, $29.8 million in Q1 2024, and $49.4 million in Q4 2023.